IRAKLI GIORGBERIDZE to Treatment Outcome
This is a "connection" page, showing publications IRAKLI GIORGBERIDZE has written about Treatment Outcome.
Connection Strength
0.130
-
Modified Pull-Through Technique for Cardiac Resynchronization Therapy Upgrades in Patients with Occluded Access Veins. Tex Heart Inst J. 2020 02; 47(1):23-26.
Score: 0.053
-
Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure. Catheter Cardiovasc Interv. 2021 11 15; 98(6):E839-E846.
Score: 0.014
-
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial. Heart Rhythm. 2021 07; 18(7):1045-1054.
Score: 0.014
-
Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial. JAMA. 2020 10 27; 324(16):1620-1628.
Score: 0.014
-
Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study. Am J Cardiol. 1997 Sep 11; 80(5B):3F-9F.
Score: 0.011
-
Effects of high-frequency atrial pacing in atypical atrial flutter and atrial fibrillation. J Interv Card Electrophysiol. 1997 Sep; 1(2):111-23.
Score: 0.011
-
Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol. 2011 Aug 04; 150(3):264-9.
Score: 0.007
-
Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator. J Interv Card Electrophysiol. 1997 Feb; 1(1):49-56.
Score: 0.003
-
New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias. Arch Mal Coeur Vaiss. 1996 Feb; 89 Spec No 1:149-54.
Score: 0.003